D-1140-2018 Class II Ongoing
FDA drug recall D-1140-2018 was initiated by Torrent Pharma Inc. on Aug 17, 2018 and is designated Class II. Reason for recall: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. The recall status is ongoing. Affected quantity: 78144 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 5, 2018
- Initiation Date
- Aug 17, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78144 bottles
Product description
Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-207-30
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Distribution pattern
Nationwide USA
Code information
Batch: BV53D004, BV53C006, BV53D001, BV53D002, BV53D003, BV53C004, BV53C005
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1140-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026